Current Pharmaceutical Design
Title: Preface
Volume: 6 Issue: 12
Author(s): Joseph P. Yevich and David W. Smith
Affiliation:
Export Options
About this article
Cite this article as:
Yevich P. Joseph and Smith W. David, Preface, Current Pharmaceutical Design 2000; 6 (12) . https://dx.doi.org/10.2174/1381612003399699
DOI https://dx.doi.org/10.2174/1381612003399699 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury
Current Pharmaceutical Design Neurogenesis as a New Target for the Development of Antidepressant Drugs
Current Pharmaceutical Design Radiofluorinated Carbohydrates for Positron Emission Tomography
Current Topics in Medicinal Chemistry Self-Regulatory Control and Habit Learning in the Development of Eating Disorders
Current Psychiatry Reviews ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Herbal Medicine for Anxiety, Depression and Insomnia
Current Neuropharmacology The Effects of Psychological Stress on Depression
Current Neuropharmacology Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
Anti-Cancer Agents in Medicinal Chemistry The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets New Glycoside Esters from the Aerial Parts of Artemisia absinthium Linn.
The Natural Products Journal Methylphenidate (Ritalin): What Makes it so Widely Prescribed During the Last 60 Years?
Current Drug Therapy Drug-Resistance in Central Nervous System Tumors: From the Traditional Cell-Resistance Model to the Genetically Driven Approaches on Therapy
Current Pharmaceutical Biotechnology Davunetide: Peptide Therapeutic in Neurological Disorders
Current Medicinal Chemistry Bioinformatics and Drug Discovery
Current Topics in Medicinal Chemistry Sodium Channel Toxins - Receptor Targeting and Therapeutic Potential
Current Medicinal Chemistry Patent Selections :
Recent Patents on CNS Drug Discovery (Discontinued) The Mammalian Tachykinin Ligand-Receptor System: An Emerging Target for Central Neurological Disorders
CNS & Neurological Disorders - Drug Targets Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Antiepileptogenic Effect of Retinoic Acid
Current Neuropharmacology Co-Existence of GABA and Glu in the Hippocampal Granule Cells: Implications for Epilepsy
Current Topics in Medicinal Chemistry